- Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trialMarc I Chimowitz
Department of Neurosciences, Stroke Center, Medical University of South Carolina, Charleston, USA
J Stroke Cerebrovasc Dis 20:357-68. 2011....
- Stenting versus aggressive medical therapy for intracranial arterial stenosisMarc I Chimowitz
Department of Neurosciences, Medical University of South Carolina, Charleston, SC 29425, USA
N Engl J Med 365:993-1003. 2011..However, PTAS has not been compared with medical management in a randomized trial...
- Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosisBruce Ovbiagele
Stroke Center, Department of Neurology, UCLA Medical Center, Los Angeles, CA, USA
Neurology 66:1344-9. 2006..The authors evaluated the prevalence and prognosis of the MetS among individuals with symptomatic intracranial arterial stenosis...
- WARFARIN VS ASPIRIN FOR INTRACRANIAL ARTERIAL STENOSISMarc Chimowitz; Fiscal Year: 2002..e., greater than or equal to 6 percent per year) to justify a subsequent trial comparing intracranial angioplasty with best medical therapy in these patients. ..